To Study Serum Ceruloplasmin Level in Early Diagnosed Patients with Subclinical Hypothyroidism

The aim of study was to measure serum level of ceruloplasmin in Subclinical hypothyroidism (SCH) subjects and compare with healthy control subjects. In this study 120 SCH and 120 healthy subjects (age and gender matched) were enrolled. BMI, Serum free triiodotyronine (FT3), Serum free thyroxin (FT4), Serum thyroid stimulating hormone (TSH) and Serum Ceruloplasmin were assessed. Serum Ceruloplasmin levels were lower in Subclinical hypothyroidism (SCH) subjects compared with healthy controls (17.8 ± 2.1 mg/dl vs 28.8 ± 5.1 mg/dl, respectively. These value were found to be statistically highly significant (pless than0.0001).